Acute myelogenous leukaemia modulated by B12 deficiency: A case with bone marrow blast cell assay corroboration

Frederick R Ahmann, B. G M Durie

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A patient is described who appeared to demonstrate modulation of acute myelogenous leukaemia with vitamin B12 deprivation. Support for this observation was obtained via an in vitro bone marrow blast cell assay. The addition of B12 to this patient's bone marrow in vitro significantly stimulated the colony forming ability of the blast cells. Patients with B12 deficiency have an increased incidence of haematopoietic malignancies and excessive replacement of B12 may in some cases have the potential of accelerating such disorders. Intensive B12 replacement in refractory megaloblastic anaemias should be done with caution.

Original languageEnglish (US)
Pages (from-to)91-94
Number of pages4
JournalBritish Journal of Haematology
Volume58
Issue number1
StatePublished - 1984

Fingerprint

Acute Myeloid Leukemia
Bone Marrow Cells
Refractory Anemia
Megaloblastic Anemia
Hematologic Neoplasms
Vitamin B 12
Bone Marrow
Incidence
In Vitro Techniques

ASJC Scopus subject areas

  • Hematology

Cite this

Acute myelogenous leukaemia modulated by B12 deficiency : A case with bone marrow blast cell assay corroboration. / Ahmann, Frederick R; Durie, B. G M.

In: British Journal of Haematology, Vol. 58, No. 1, 1984, p. 91-94.

Research output: Contribution to journalArticle

@article{262565fc80eb4579a2557dc4eecd0c9b,
title = "Acute myelogenous leukaemia modulated by B12 deficiency: A case with bone marrow blast cell assay corroboration",
abstract = "A patient is described who appeared to demonstrate modulation of acute myelogenous leukaemia with vitamin B12 deprivation. Support for this observation was obtained via an in vitro bone marrow blast cell assay. The addition of B12 to this patient's bone marrow in vitro significantly stimulated the colony forming ability of the blast cells. Patients with B12 deficiency have an increased incidence of haematopoietic malignancies and excessive replacement of B12 may in some cases have the potential of accelerating such disorders. Intensive B12 replacement in refractory megaloblastic anaemias should be done with caution.",
author = "Ahmann, {Frederick R} and Durie, {B. G M}",
year = "1984",
language = "English (US)",
volume = "58",
pages = "91--94",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Acute myelogenous leukaemia modulated by B12 deficiency

T2 - A case with bone marrow blast cell assay corroboration

AU - Ahmann, Frederick R

AU - Durie, B. G M

PY - 1984

Y1 - 1984

N2 - A patient is described who appeared to demonstrate modulation of acute myelogenous leukaemia with vitamin B12 deprivation. Support for this observation was obtained via an in vitro bone marrow blast cell assay. The addition of B12 to this patient's bone marrow in vitro significantly stimulated the colony forming ability of the blast cells. Patients with B12 deficiency have an increased incidence of haematopoietic malignancies and excessive replacement of B12 may in some cases have the potential of accelerating such disorders. Intensive B12 replacement in refractory megaloblastic anaemias should be done with caution.

AB - A patient is described who appeared to demonstrate modulation of acute myelogenous leukaemia with vitamin B12 deprivation. Support for this observation was obtained via an in vitro bone marrow blast cell assay. The addition of B12 to this patient's bone marrow in vitro significantly stimulated the colony forming ability of the blast cells. Patients with B12 deficiency have an increased incidence of haematopoietic malignancies and excessive replacement of B12 may in some cases have the potential of accelerating such disorders. Intensive B12 replacement in refractory megaloblastic anaemias should be done with caution.

UR - http://www.scopus.com/inward/record.url?scp=0021123751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021123751&partnerID=8YFLogxK

M3 - Article

C2 - 6590092

AN - SCOPUS:0021123751

VL - 58

SP - 91

EP - 94

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -